TD2 Oncology
TD2 Oncology is a global, science-driven oncology CRO with deep expertise in radiopharmaceutical clinical trials. We offer end-to-end services including protocol design, regulatory strategy, site and patient management, imaging integration, and quality oversight to streamline development and reduce timelines. With 15+ years of experience and a proven track record in complex radiopharmaceuticals, TD2 supports sponsors from early phase through approval, ensuring precision, compliance, and accelerated advancement of next-generation cancer therapies.
